Synthetic human α-atrial natriuretic peptide infusion in management after open heart operations

ASAIO Journal

Volumn 49, Issue 3, 2003, Pages 320-324

  Hayashi, Yoshitaka ^a   Ohtani, Masakatsu ^b   Hiraishi, Taizo ^b   Kosayashi, Yasuhiko ^b   Nakamura, Takayuki ^b  

^a MINAMI OSAKA GENERAL HOSPITAL   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATION ANALYSIS; OPERATING ROOMS; POTASSIUM COMPOUNDS; PULMONARY DISEASES;

CARDIOPULMONARY BYPASS; DIURETIC EFFECT;

CARDIOLOGY;

ALDOSTERONE; ATRIAL NATRIURETIC FACTOR ALPHA; FUROSEMIDE; POTASSIUM; RENIN;

ADULT; AGED; ALDOSTERONE BLOOD LEVEL; ARTICLE; CARDIOPULMONARY BYPASS; CENTRAL VENOUS PRESSURE; CONTROLLED STUDY; DIURESIS; DOSE RESPONSE; DRUG ACTIVITY; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG MECHANISM; ELECTIVE SURGERY; ENZYME ACTIVITY; FEMALE; HOMEOSTASIS; HUMAN; LUNG ARTERY PRESSURE; LUNG CAPILLARY PRESSURE; MALE; OPEN HEART SURGERY; PLASMA RENIN ACTIVITY; PLASMA VOLUME; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; WATER RETENTION;

AGED; ALDOSTERONE; ATRIAL NATRIURETIC FACTOR; CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; EDEMA; FEMALE; HUMANS; INFUSIONS, INTRA-ARTERIAL; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE PERIOD; RENIN; RENIN-ANGIOTENSIN SYSTEM;

EID: 0038218168     PISSN: 10582916     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.MAT.0000065370.44623.6E     Document Type: Article

References (16)

1. Ramsay JG: The respiratory, renal, and hepatic systems: effects of cardiac surgery and cardiopulmonary bypass, in Mora CT (ed), Cardiopulmonary Bypass. New York: Springer-Verlag, 1995: pp. 147-168.
2. Downing SW, Edmunds LH Jr: Release of vasoactive substances during cardiopulmonary bypass. Ann Thorac Surg 54: 1236-1243, 1992.
3. Gonnely TP, Francis GS, Williams KJ, Beltran AM, Cohn JN: Interaction of intravenous atrial natriuretic factor with furosemide in patients with heart failure. Am Heart J 127: 392-399, 1994.
4. Lang RE, Tholken H, Ganten D, Luft FC, Ruskoaho H, Unger T: Atrial natriuretic factor-circulating hormone atimulated by volume loading. Nature 314: 2642-2647, 1985.
5. Maack Y, Marison DN, Camargo MJE, et al: Effects of synthetic natriuretic factor on kidney function and the renin-aldosterone system in the dogs. Am J Med 77: 1069-1075, 1984.
6. Kangawa K, Matsuo H: Purification and complete amino acid sequence of α-human atrial natriuretic polypeptide (α-hANP). Biochem Biophys Res Commun 120: 333-338, 1984.
7. Saito Y, Nakao K, Nishimura K, et al: Clinical application of atrial natriuretic peptide in patients with congestive heart failure: beneficial effects on left ventricular function. Circulation 76: 115-124, 1987.
8. Yoshimura M, Yasue H, Okumura K, et al: Different secretion patterns of atrial natriuretic peptide in patients with severe heart failure. Circulation 87: 464-469, 1993.
9. Pang LM, Stalcup SA, Lipset JS, Hayes CJ, Bowman FO, Mellins RB: Increased circulating bradykinin during hypothermia and cardiopulmonary bypass in children. Circulation 60: 1503-1507, 1979.
10. Steinberg JB, Kapelanski DP, Olson J, Weiler JM: Cytokine and complement levels in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 106: 1008-1016, 1993.
11. Schaff HV, Mashburn JP, McCarthy PM, Torres EJ, Burnett JC: Natriuresis during and early after cardiopulmonary bypass: Relationship to atrial natriuretic factor, aldosterone, and antidiuretic hormone. J Thorac Cardiovasc Surg 98: 979-986, 1989.
12. Maack T: Receptors of atrial natriuretic factor. Annu Rev Physiol 54: 11-27, 1992.
13. Charles CJ, Espiner EA, Nicholls MG, et al: Clearance receptors and endopeptidase 24.11: Equal role in natriuretic peptide metabolism in conscious sheep. Am J Physiol 271: R373-R380, 1996.
14. Nishimura K, Matsuda K, Konno S, et al: Beneficial effect of synthetic human atrial natriuretic polypeptide on renal function in a patient with giant atria. J Thorac Cardiovasc Surg 113: 793-795, 1997.
15. Maeda K, Tsutamoto T, Wada A, et al: Low dose synthetic atrial natriuretic peptide infusion in a patient with mitral stenosis and severe pulmonary hypertension. Jpn Circ J 63: 816-818, 1999.
16. Hayashi Y, Ohtani M, Hiraishi T, Kobayashi Y: Postoperative synthetic human atrial natriuretic peptide infusion and oral spironolactone administration for a patient with giant atria and low plasma level of atrial natriuretic peptide. J Thorac Cardiovasc Surg 124: 206-209, 2002.